Article ID Journal Published Year Pages File Type
5038268 Behaviour Research and Therapy 2017 9 Pages PDF
Abstract

•Patients with anxiety and related disorders were assessed for end-tidal CO2 (ETCO2) prior to receiving cognitive-behavioral therapy (CBT) in an outpatient clinic.•Lower pre-treatment ETCO2 predicted premature dropout from CBT.•Hyperventilation, as evidenced by lower ETCO2, is a poor prognostic indicator for CBT.

Recent clinical trial research suggests that baseline low end-tidal CO2 (ETCO2, the biological marker of hyperventilation) may predict poorer response to cognitive-behavioral therapy (CBT) for anxiety-related disorders. The present study examined the predictive value of baseline ETCO2 among patients treated for such disorders in a naturalistic clinical setting. Sixty-nine adults with a primary diagnosis of a DSM-5 anxiety disorder, obsessive-compulsive disorder, or posttraumatic stress disorder completed a 4-min assessment of resting ETCO2, and respiration rate (the first minute was analyzed). Lower ETCO2 was not associated with a diagnosis of panic disorder, and was associated with lower subjective distress ratings on certain measures. Baseline ETCO2 significantly predicted treatment dropout: those meeting cutoff criteria for hypocapnia were more than twice as likely to drop out of treatment, and ETCO2 significantly predicted dropout beyond other pre-treatment variables. Weekly measurement suggested that the lower-ETCO2 patients who dropped out were not responding well to treatment prior to dropout. The present results, along with previous clinical trial data, suggest that lower pre-treatment ETCO2 is a negative prognostic indicator for CBT for anxiety-related disorders. It is suggested that patients with lower ETCO2 might benefit from additional intervention that targets respiratory abnormality.

Related Topics
Health Sciences Medicine and Dentistry Psychiatry and Mental Health
Authors
, , , ,